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Abstract:  
In the solid state (±)-3-methyl-2-phenylbutyramide 1 spontaneously resolves into a conglomerate 
(Form I) that crystallizes in a racemic form (Form II) upon melting followed by vapor 
crystallization, a rarely reported phenomenon. An additional racemic polymorph, Form III, has 
been characterized, and the thermodynamic relationship between the three forms established by a 
variety of computational and experimental methods including grinding, slurry crystallization and 
seeding techniques. Both racemic Forms II and III are metastable and readily convert to the more 
stable conglomerate, Form I. Density Functional Theory calculations of the different polymorphs 
of 1 show that the enantiomers of 1 (R & S) are more stable than both racemic forms. 
 
Introduction: 
The racemic and enantiopure forms of a pharmaceutical compound often display distinct 
physiological and pharmacological properties in living organisms.1-3 Many chiral pharmaceutical 
compounds in the market were historically developed as racemates.4 Specific guidelines for the 
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marketing of the bio-active enantiomer of an active pharmaceutical ingredient (API) have been 
provided by the FDA since 1992, to ensure safety.5-6 These directives stipulate that each isomer 
and racemic form of an API should be studied separately to understand their pharmacological 
activity and metabolic pathways. Therefore, obtaining enantiopure compounds has received 
tremendous attention from both academic and industrial researchers over the last few decades.7 
This has provided a strong stimulus for the development of methodologies for the asymmetric 
synthesis of organic compounds.8 From the solid-state perspective, a racemic mixture can 
crystallize in three ways: a racemic compound (hereafter called a ‘racemate’), a racemic 
conglomerate (hereafter called a ‘conglomerate’) or a solid solution.9 A racemate contains an 
equal ratio of both enantiomers in its crystal lattice with its molecules in a regular, usually 
centrosymmetric, arrangement.10 A conglomerate is a physical mixture of both enantiomers that 
crystallize separately during the crystallization process; this is also referred to as spontaneous 
resolution.11 A solid solution has both enantiomers present in the lattice in an unordered manner. 
It often happens when the two enantiomers compete for the same position in its crystal lattice, 
and the term “pseudo racemates” has also been used to describe this phenomenon.12 
Conglomerates are relatively rare, with this behavior observed for organic molecules about 5-
10% cases in the Cambridge Structural Database, whereas racemates predominate and solid 
solutions occur rarely.13-15 The importance of understanding the interaction between enantiomers 
of chiral compounds used as pharmaceuticals16-17 has been highlighted through a recent report of 
a more stable racemic form of Pioglitazone Hydrochloride, which has been marketed as a 
conglomerate for many years.18 
One of the common inexpensive methods to resolve the enantiomers of a compound on an 
industrial scale is the entrainment procedure, where the desired enantiomer is used as a seed in 
the crystallization step to obtain a pure product consisting only of the same enantiomer.19-22 
However, this method can only be used for chiral resolution when the compound crystallizes as a 
conglomerate.23 Diastereomeric salt formation is a related method that has been used to 
crystallize the preferred enantiomer from a racemic mixture.24  
Understanding the interconversion and stability relationships between racemic and conglomerate 
forms is an important step in the crystallization of an API.25-31 In this context, we have examined 
the crystallization behavior of 3-methyl-2-phenylbutyramide, 1, an antimitotic compound that 
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displays racemic and conglomerate forms, Figure 1. Notably, the solid-state properties of 1 have 
not been described previously. 
 
Figure 1. Structure of 3-methyl-2-phenylbutyramide, 1. 
 
Experimental 
Materials and methods. Racemic 3-methyl-2-phenylbutyric acid was purchased from Alfa 
Aesar. (R)-3-Methyl-2-phenylbutyric acid was purchased from Sigma-Aldrich and (S)-3-methyl-
2-phenylbutyric acid was purchased from Fluorochem. All solvents were purchased from Sigma-
Aldrich and used directly, without any further purification.  
(±)-3-Methyl-2-phenylbutyramide, (±)-1. This was synthesized from (±)-3-methyl-2-
phenylbutyricic acid using the reported procedure.32 1H NMR: δH (300 MHz, CDCl3) :  7.38-7.23 
(m, 5H), 5.47 (br s, 2H), 2.91 (d, J = 10.2 Hz, 1H), 2.48-2.30 (m, 1H), 1.08 (d, J = 6.5 Hz, 3H), 
0.71 (d, J = 6.7 Hz, 3H). Anal. Calcd for C11H15NO: C, 74.54; H, 8.53; N, 7.90; Found: C, 74.29; 
H, 8.62; N, 7.98, mp: 105-107 ⁰C. All spectroscopic details for 1 agreed with those previously 
reported.32 Crystals suitable for single crystal analysis were grown from ethanol and called Form 
I.  
(R)-3-Methyl-2-phenylbutyramide, (R)-1. To a flask containing (R)-3-methyl-2-phenylbutyric 
acid (0.15 g, 0.842 mmol) was added thionyl chloride (0.8 mL, 1.1 mmol, 1.3 equiv.) while 
maintaining the temperature at 0 °C. The solution was let warm to room temperature and stirred 
for 20 h. The excess thionyl chloride was removed under reduced pressure at room temperature 
to give a yellow liquid. This was dissolved in CH2Cl2 (1 mL) and the solution was added 
dropwise to aqueous ammonia solution (32%, 0.15 mL). This gave a white precipitate which was 
dissolved in CH2Cl2 (30 mL) and washed with water (3 x 20 mL) and brine (30 mL). The solvent 
was removed under in vacuo to give pure (R)-1 as a white solid (0.140 g, 93%) with identical 
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spectroscopic characteristics to (±)-1. 1H NMR: δH (300 MHz, CDCl3):  7.38-7.23 (m, 5H), 5.47 
(br s, 2H), 2.91 (d, J = 10.2 Hz, 1H), 2.48-2.30 (m, 1H), 1.08 (d, J = 6.5 Hz, 3H), 0.71 (d, J = 6.7 
Hz, 3H), 13C NMR δ (75 MHz, CDCl3): 175.6, 139.1, 128.6, 128.3, 127.2, 61.1, 31.2, 21.6, 20.3. 
Anal. Calcd for C11H15NO: C, 74.54; H, 8.53; N, 7.90; Found: C, 74.64; H, 8.49; N, 7.83, m.p.: 
138-140 °C.  
(S)-3-Methyl-2-phenylbutyramide, (S)-1. This was synthesized from (S)-3-methyl-2-
phenylbutyric acid following the procedure for (R)-1 to give 0.143 g (95%) of pure (S)-1. 1H 
NMR: δH (300 MHz, CDCl3):  7.38-7.23 (m, 5H), 5.47 (br s, 2H), 2.91 (d, J = 10.2 Hz, 1H), 
2.48-2.30 (m, 1H), 1.08 (d, J = 6.5 Hz, 3H), 0.71 (d, J = 6.7 Hz, 3H). Anal. Calcd for C11H15NO: 
C, 74.54; H, 8.53; N, 7.90; Found: C, 74.61; H, 8.48; N, 7.70, m.p.: 138-140 °C. Analysis 
matches the reported literature.33  
Crystallization of conglomerate, Form I.  
A wide variety of different crystallization conditions were examined. For all experiments Form I 
(~50 mg) was placed in a sample vial, solvent (10 mL) added and the sample vial heated gently 
until dissolution occurred. The resulting clear solution was filtered using a 0.45 micron filter 
fitted to a 10 mL syringe. A variety of different solvents and solvent mixtures were investigated: 
methanol, ethanol, acetonitrile, tetrahydrofuran, dichloromethane, water / methanol (50:50) and 
hexane / chloroform (50:50). For cooling crystallization experiments, the solutions were either 
allowed to cool to room temperature, or placed directly into the freezer compartment of a fridge 
(−4 °C). For solvent evaporation experiments, samples were left to stand at room temperature, or 
−4 °C, until dry. In certain instances, a rotary evaporator was used.34,35 
Crystallization of (±)-Form II. The synthesized (±)-1 (2.00 g, 11.3 mmol) was placed in the 
outer vessel of a sublimation apparatus, which was heated to 150 °C, and the internal cold finger 
was cooled with water circulating at ~10 °C. (At these conditions, (±)-1 was in its liquid phase 
and vapors of (±)-1 crystallized on the cold finger surface. No decomposition of (±)-1 was 
observed) The outer vessel was maintained at 150 °C for 3 h, producing needle crystals of pure 
racemic Form II on the cold finger (1.86 g, 93% yield). Anal. Calcd for Form II crystals 
C11H15NO: C, 74.54; H, 8.53; N, 7.90; Found: C, 74.50; H, 8.55; N, 8.10, m.p.: 110-112 °C. 
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Crystallization of (±)-Form III. Crystals of Form II (1.00 g, 5.64 mmol) were placed in a 
25 mL conical flask which was placed on a hot plate (~120 ºC) until all the solid had melted. 
Acetonitrile (10 mL) was added dropwise over 15 min. [Alternatively, the first step, heating until 
the solid melted, can be replaced by simply dissolving Form II in acetonitrile (10 mL)]. The 
resulting clear solution was removed from the hot plate, filtered using a 0.2 micron filter fitted to 
a 10 mL syringe, cooled to room temperature and placed into a fridge (−4 °C) for 2 d. Crystals of 
racemic Form III (blocks) and the conglomerate Form I (needles) crystallized concomitantly and 
were manually separated. Anal. Calcd for Form III crystals, C11H15NO: C, 74.54; H, 8.53; N, 
7.90; Found: C, 74.58; H, 8.60; N, 8.12, m.p.: 112-114 °C. 
Mechanical grinding. Mechanical grinding was carried out in a Retsch MM−00 Mixer mill, 
equipped with two stainless steel 5 mL grinding jars and one 2.5 mm stainless steel grinding ball 
per jar. The mill was operated at a rate of 30 Hz for 30 min and the typical sample size was 150-
200 mg. 
Slurry experiments. Slurry experiments were carried out with typically 150-200 mg of the 
sample placed in a 25 mL round bottomed flask, to which was added 2-3 mL of a solvent. After 
stirring for ~10 min at room temperature, 2-4 mg of seed crystals were added and the mixture 
stirred for a further 24 hours at room temperature. A detailed list of solvent, type of seed and the 
experimental outcomes are presented in Table 3 in the Supporting Information.  
Manual grinding. Manual grinding was undertaken using a mortar and pestle with the typical 
sample size of 200-250 mg for 20 min. for both dry grinding and solvent drop grinding (using 2-
3 drops of solvent).  
Infrared Spectroscopy. Infrared spectra were recorded on a Bruker Tensor 37 attenuated total 
reflection (ATR)-IR spectrophotometer interfaced with Opus software version 7.2.139.1294 over 
a range of 400 – 4000 cm-1. An average of 16 scans was taken for each spectrum obtained.  
Powder X-Ray Diffraction. PXRD data were collected using a D2 phaser diffractometer using 
Cu Kα (λ = 1.5406 Å) radiation. Samples were analyzed over a 2θ range of 3.5−45° with 
increments of 0.05° at a rate of 2° min-1. Data were evaluated using the DIFFRAC.Eva (Bruker 
AXS Inc.) software. 
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Nuclear Magnetic Resonance. 1H (300 MHz) and 13C (75.5 MHz) NMR spectra were recorded 
on a Bruker Avance 300 MHz NMR spectrometer. All spectra were recorded at room 
temperature (20 ºC) in deuterated chloroform (CDCl3), using tetramethylsilane (TMS) as an 
internal standard. Chemical shifts (δH & δC) are reported in parts per million (ppm) relative to 
TMS and coupling constants are expressed in Hertz (Hz).  
High Performance Liquid Chromatography (HPLC). Chiral HPLC analysis was conducted 
on a Waters Alliance 2690 separations module with a PDA detector. The enantiomeric purities 
were determined by analysis on a Chiralcel OD-H column (5 x 250 mm), purchased from Daicel 
Chemical Industries, Japan. The mobile phase was a 90:10 mixture of hexane:2-propanol, the 
flow rate was 1 mL min−1 and the detection wavelength was at 209.8 nm. The experiments were 
carried out at 25 °C. 
Differential Scanning Calorimetry (DSC). All melting points were obtained from a TA Q1000 
instrument. Samples (2–6 mg) were crimped in nonhermetic aluminum pans and scanned from 
30 to 160 °C at a heating rate of 10 °C min−1 under a continuously purged dry nitrogen 
atmosphere. 
Elemental analysis. An Exeter Analytical CE440 was used for elemental analysis. 
Single Crystal X-ray Diffraction. Single crystal X-ray data was collected on a Bruker APEX II 
DUO diffractometer,36 using graphite monochromatized Mo Kα (λ = 0.7107 Å) radiation for the 
racemic forms and Incoatec montel multilayer mirror monochromatized Cu Kα (λ = 1.5418 Å) 
radiation for the R and S enantiomers. The APEX suite of programmes,37 incorporating the 
SHELX suite of programs,38 were used. The structures were solved using direct methods and 
refined by full-matrix least-squares on F2. All non-hydrogen atoms were located and refined with 
anisotropic thermal parameters. Hydrogen atoms were either placed in calculated positions or 
located and refined with isotropic thermal parameters. Diagrams were prepared with Mercury 
3.8.39 The crystallographic data are summarized in Table 1. 
 
Table 1. Crystallographic data for both enantiomers and the two racemic forms 
Compound R Form S Form Form II Form III 
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Formula C11 H15 N1 O1 C11 H15 N1 O1 C11 H15 N1 O1 C11 H15 N1 O1 
MW 177.24 177.24 177.24 177.24 
crystal system monoclinic monoclinic monoclinic monoclinic 
space group, Z P21, 4 P21, 4 P21/c, 4 P21/n, 8 
a, Å 15.0554(16) 15.0331(4) 12.017(6) 9.1071(10) 
b, Å 5.2629(2) 5.26050(10) 5.158(3) 24.498(3) 
c, Å 15.1388(6) 15.1573(4) 17.526(9) 10.49(2) 
β, ° 116.996(2) 116.9520(10) 93.757(13) 112.545(2) 
V, Å3 1068.82(7) 1068.47(5) 1084.0(10) 2141.2(4) 
Dc, g cm−3 1.101 1.102 1.086 1.100 
Wavelength, Å  1.5418 1.5418 0.7107 0.7107 
µ, mm−1 0.552 0.552 0.069 0.069 
θ range, deg 3.28-67.12 3.27-66.49 1.70-25.09 1.66-26.40 
T, K 296 296 296 296 
total reflns 10337 10451 12380 33023 
unique reflns 3655 3643 1896 4390 
Rint 0.0353 0.0205 0.0423 0.0287 
obs. refns, I > 2σ(I) 3530 3570 1226 3647 
no. parameters 255 255 152 255 
no. restraints 1 1 0 0 
R1 [I > 2σ(I)] 0.0862 0.0320 0.0431 0.0448 
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wR2 [all data] 0.2252 0.0877 0.1254 0.1175 
S 1.135 1.052 1.010 1.082 
Flack parameter 0.06(12) 0.08(6) -- -- 
ρmax, ρmin, e Å
−3
 0.893, -0.250 0.158, -0.129 0.221, -0.159 0.179, -0.169 
 
Density Functional Theory Modelling 
Density functional theory (DFT) simulations were applied to analyze the relative stability of the 
the different crystal forms of 1 and understand their energetic ordering. The initial crystal and 
atomic structures were taken from the experimental *.cif. DFT simulations were carried out 
using the VASP5.340 simulation code – the valence electrons were described in a periodic plane 
wave basis set with a cut off energy of 450 eV. The interaction between the core and valence 
electrons were described by the projector augmented wave approach41 with 6, 5, 4 and 1 valence 
electron for O, N, C and H, respectively. The Perdew-Burke-Ernzerhof (PBE) GGA 
approximation to the exchange-correlation functional was applied.42 Two hybrid DFT 
functionals were also applied, namely HSE06 and PBE0.43,44 The HSE06 and PBE0 calculations 
use the default parameters of 25% exact HF exchange and, in HSE06, a screening length of 5 Å. 
Grimme’s D2 and D3 models were used to include two different descriptions of the vdW 
interactions,45,46 giving PBE-D2/PBE-D3, HSE06-D2/HSE06-D3 and PBE0-D2/PBE0-D3 
theoretical models.  
Initially, all atomic positions were relaxed with no symmetry imposed with convergence criteria 
in the energy and ionic relaxations of 1x10−5 eV and 0.01 eV Å−1, respectively. Then the lattices 
were relaxed, with both lattice dimensions and angles being allowed to vary. We used direct 
lattice relaxations and an iterative procedure in which atomic positions are relaxed, followed by 
cell relaxation and repeating this process. The latter procedure avoids any issues arising from an 
incomplete plane wave basis set during simultaneous ion and cell relaxations; however, similar 
results were obtained for the lattice parameters in both approaches. Methfessel-Paxton Fermi 
level smearing was applied with a value of σ = 0.1 eV. The quasi-Newton relaxation algorithm 
was applied for the atomic relaxations. 
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Results and discussion 
Conglomerate, Form I 
(±)-3-Methyl-2-phenylbutyramide 1 was synthesized from (±)-3-methyl-2-phenylbutyric acid 
and crystallized from a variety of solvents. Crystals of Form I suitable for single crystal 
diffraction were obtained as needles by slow evaporation from ethanol and analysis revealed the 
S enantiomer had crystallized in the Sohncke space group P21 with Z′ = 2. The experimental 
PXRD pattern of the synthesized amide matches the theoretical PXRD pattern based on this 
single crystal analysis, suggesting spontaneous resolution during crystallization and the 
formation of a conglomerate.  
Analysis of 6 randomly picked crystals of Form I obtained from the ethanol crystallization batch 
revealed that they had all spontaneously resolved into the conglomerate, with no evidence of any 
other crystal form. This approach allowed both R and S enantiomers to be successfully 
characterized (both in P21 with Z′ = 2). Difficulties were experienced in finding good quality 
single crystals, particularly for the R enantiomer, because most of the crystals stick to each other 
along the needle axis. By applying pressure with a needle, it was possible to separate the crystal, 
albeit with much smaller crystallites remaining adhered to the main needle. However, the 
absolute configurations of both enantiomers, (R)-1 & (S)-1, have been established basing on the 
anomalous dispersion effects.  
Crystal structure analysis of each enantiomer shows two crystallographically unique molecules 
in the asymmetric unit which interact with each other through infinite N-H···O=C hydrogen 
bonding. One of the amide hydrogen atoms forms R2
2
(8) dimers, while the other amide hydrogen 
atom forms C(4) chains of the same symmetry molecules, also via N-H···O=C hydrogen 
bonding, leading to the well-known 1-D infinite ribbons, Figure 2.  
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Figure 2. Crystal packing in S enantiomer (left) and R enantiomer (right).  
 
To investigate further the formation of the conglomerate, the synthesis of the individual 
enantiopure enantiomers (R)-1 and (S)-1 was undertaken. While crystallization of either the R or 
S enantiopure material was attempted using a variety of solvents and crystallization techniques, 
crystals suitable for single crystal analysis could not be obtained in either case. However, the 
experimental PXRD pattern for samples of each enantiomer from these crystallization 
experiments match the calculated diffraction patterns generated from the single crystal data of 
Form I. The chiral HPLC analysis also confirms the spontaneous resolution during crystallization 
of (±)-1 to form the conglomerate, Form I (see Supporting Information). 
 
Racemic Polymorphs, Forms II and III 
Crystallization of the amide was examined using a variety of methods including: fast and slow 
solvent evaporation in different organic solvents at different temperatures, crystallization from 
the melt by cooling to RT, mechanical grinding using either a mortar-pestle or a mixer mill, fast 
evaporation using a rotatory evaporator and melting followed by vapor crystallization.47-49 
Further details are provided in Table 3 in the Supporting Information. All these approaches 
yielded the conglomerate, except for evaporation from the melt, which gave rise to needle 
crystals of a new form that single crystal analysis revealed adopted the racemic space group 
P21/c with Z′ = 1, termed Form II. Subsequently, a third form, Form III, was obtained as block 
crystals concomitantly with Form I by crystallizing from acetonitrile and placing in a fridge at −4 
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°C (see Experimental). This was determined to be a second racemic form, crystallizing in P21/n 
with Z′ = 2. Different Z′ values50 are seen in Forms II and III. 
In both Forms II and III, the amides interact via N-H···O=C hydrogen bonding by the formation 
of R2
2
(8) dimers and C(4) chains to form the familiar ladder motif. For Form II, all the R 
enantiomers are located on one side of the ladder motif and the S enantiomers located on the 
opposite side due to inversion centers present in the middle of both the R2
2
(8) dimers and the 
binary level R2
4
(8) tetramers (Figure 3, left). In Form III, the inversion centers are only present in 
the middle of the R2
2
(8) dimer, leading to an alternating arrangement of R and S enantiomers 
along each side of the ladder motif (Figure 3, right). The infinite ribbons are packed further in a 
parquet pattern in both forms. 
    
Figure 3 Comparison between the two racemic forms: Form II, left, and Form III, right. [R and S 
enantiomers, are colored blue and green, respectively, and the orange dots indicate the inversion 
centres.]  
There are small, but significant, differences in the hydrogen bonding and IR data for the different 
forms, Table 2 (The IR data for the R and S Form are identical, so only the S Form is presented). 
The IR data for Form II for the C=O stretch (1699 cm−1) and the N-H stretch (3161 cm−1) are 
notably different to the corresponding data for Forms I, (1650 cm−1, 3187 cm−1) and III (1651 
cm−1, 3184 cm−1). While this observation is not readily rationalized by analysis of bond lengths, 
angles, torsion angles and planarity of the nitrogen in the different forms, superimposition of the 
molecules indicate the conformation of the amides differ slightly across the three forms, 
presumably impacting on the IR data (see Figure 12 in the Supporting Information).  
Page 11 of 25
ACS Paragon Plus Environment






























































Table 2. Comparison of the different forms of 1 
 S Form Form II Form III 
N-H···O=C, Å 2.08(2) 2.07(2) 1.985(2) 
N-H···O, ° 150.50(2) 142.97(2) 152.55(2) 
νC=O, cm
−1 1650 1699 1651 
νN-H, cm
−1 3403, 3186 3393, 3161 3399, 3184 
C=O Bond length, Å 1.228(2) 1.242(2) 1.234(2) 
C-N Bond length, Å 1.326(3) 1.324(2) 1.325(2) 
 
Interconversion experiments between conglomerate and racemates 
In general, racemic compounds are thermodynamically more stable in comparison with the 
conglomerates.51 Sublimation of racemic material can result in the formation of 
conglomerates.52-55 It is rare for a conglomerate to convert to the racemate upon sublimation and 
we found only one report with such behavior.56 Notably, in this reported case the conversion is a 
solid-to-solid process while in our work the racemate is formed by evaporation, i.e. melting 
followed by crystallization. Repeated experiments were undertaken to obtain sufficient quantities 
of the racemic Forms II and III. Both racemic forms readily reconvert to the conglomerate upon 
melting or recrystallization from solvents, suggesting that the conglomerate is more stable than 
either racemic form (see Table 3 in SI for details). As described earlier, Form II can be converted 
to a mixture of Forms I and III through low temperature crystallization from acetonitrile. 
Differential scanning calorimetry (DSC) revealed sharp melting endotherms and no high 
temperature transitions were seen for any of the forms. It has been reported that if the melting 
point of an enantiopure material is higher than that of the corresponding racemic material by 25 
°C or greater, then that compound is expected to show spontaneous resolution behavior.57 For 1 
the differences in melting point between the R (or S) Form and Forms II and III are 28 °C and 26 
°C, respectively, Table 3; spontaneous resolution is observed, in agreement with this empirical 
rule. A range of slurry experiments in different solvent media, both with and without seeding, 
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were performed to investigate the relative stability of the different forms. Form I was obtained 
exclusively in all the experiments, indicating that it is the most stable form in the conditions 
examined. 
Table 3. Melting point for solid forms of 1 
Type of solid form Melting point, °C 
Form I a 105-108  
R enantiomer 138-140 
S enantiomer 138-140 
Form II 110-112 
Form III 112-114 
a conglomerate of R and S  
 
Mechanical grinding, an environmentally friendly method,58,59 has been used to study the 
interconversion between polymorphs and establish their relative stabilities, although it does not 
necessarily yield the thermodynamically stable form.60 Both manual (mortar-pestle) and 
mechanical (ball mill) methods were utilized for investigating the stability of the conglomerate 
and racemic forms of 1. In all cases the conglomerate was the product obtained from the grinding 
experiments. Slurry crystallization and crystallization by seeding experiments also resulted in the 
transformation of the racemic forms to the conglomerate. The relationships between all the forms 
and routes to obtain them are summarized in Figure 4. 
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Figure 4. Schematic representation of the behavior of the solid forms of 1.  
 
 
DFT results on the stability of the crystal structures. 
We have used density functional theory (DFT) simulations to examine the stability and structure 
of the crystal forms of 1 produced in the experiments. The DFT derived atomic structure of the S 
enantiomer, the R enantiomer and the two racemic forms, racemic Form-II and racemic Form-III 
that are derived from atomic and lattice relaxations are available in the SI. Table 4 gives the 
computed lattice vectors and angles from the following DFT set-ups: PBE+vdW, HSE06+vdW 
and PBE0+vdW cell relaxations. The vdW interactions are the D2 and D3 and these are used for 
each exchange-correlation functional. 
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Comparison of the lattice parameters with the experimental data in Table 1 reveals that the PBE 
functional gives the smallest deviations from the experimental lattice parameters. By contrast, 
the HSE exchange-correlation functional can give very large deviations of up to 10% while the 
PBE0 functional can give deviations of ca. 5%, which is still significant. The crystal form that is 
most sensitive to the DFT set-up is the R form which shows the very strong deviations just 
described. This finding is robust to the choice of input structure, e.g. whether the relaxation 
begins from the experimental lattice or the PBE-D2 lattice. The cell angle β is much less senstive 
to the choice of DFT functional for each crystal form. Finally, the effect of the form of the vdW 
correction on the compuated lattice vectors and angles is much smaller and so the performance 
of both vdW corrections appears to be similar and, thus, it is the underlying exchange-correlation 
functional that gives the most significant differences. 
Table 4. Computed lattice vectors and cell angle β for the enantiomers and racemic forms of 1. 
The theoretical methods are explained as follows: PBE-D2: atomic and cell relaxations using 
PBE with Grimme D2 van der Waals correction. PBE-D3: atomic and cell relaxations using PBE 
with Grimme D3 van der Waals correction. HSE06-D2: atomic and cell relaxations using HSE06 
with Grimme D2 van der Waals correction. HSE06-D3: atomic and cell relaxations using HSE06 
with Grimme D3 van der Waals correction. PBE0-D2: atomic and cell relaxations using PBE0 
with Grimme D2 van der Waals correction. PBE0-D3: atomic and cell relaxations using PBE0 
with Grimme D3 van der Waals correction 
PBE-D2 
 S Form R Form Racemic Form II Racemic Form III 
a, Å 14.603 14.556 11.398 8.932 
b, Å 4.623 4.619 4.593 24.266 
c, Å 14.691 14.598 17.453 10.016 
β, ° 117.33 117.4 92.970 112.041 
PBE-D3 
 S Form R Form Racemic Form II Racemic Form III 
a, Å 14.696 14.629 11.740 8.937 
Page 15 of 25
ACS Paragon Plus Environment






























































b, Å 4.649 4.656 4.604 24.219 
c, Å 14.791 14.675 17.616 10.034 
β, ° 117.359 117.237 93.021 112.08 
HSE06-D2 
 S Form R Form Racemic Form II Racemic Form III 
a, Å 14.143 13.64 11.122 8.861 
b, Å 4.547 4.446 4.526 24.135 
c, Å 14.217 13.681 17.309 9.943 
β, ° 116.623 117.823 92.761 112.028 
HSE06-D3 
 S Form R Form Racemic Form II Racemic Form III 
a, Å 14.168 12.778 10.968 8.854 
b, Å 4.575 4.975 4.547 24.150 
c, Å 14.242 12.8365 17.236 9.946 
β, ° 116.294 109.826 92.954 112.024 
PBE0-D2 
 S Form R Form Racemic Form II Racemic Form III 
a, Å 14.304 13.071 11.216 8.881 
b, Å 4.963 4.693 4.489 24.118 
c, Å 14.405 13.111 17.362 9.962 
β, ° 116.041 114.925 92.706 112.061 
PBE0-D3 
 S Form R Form Racemic Form II Racemic Form III 
a, Å 14.553 13.6004 11.223 8.906 
b, Å 4.787 4.508 4.5001 24.209 
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c, Å 92.525 13.638 17.381 9.965 
β, ° 117.013 117.403 92.672 112.018 
 
Table 5 provides the relative energies of each crystal form in kJ mol−1, where the structure with 
zero energy is the most stable form. Together with the crystal structure data, this allows us to 
explore the suitabilitiy of, and any dependencies on, the choice of DFT exchange-correlation 
functional. From the energy data in Table 5, it appears that the S enantiomer and the R 
enantiomer are generally very close in energy, with a maximum difference of less than 1 kJ 
mol−1 with PBE-D2 or PBE-D3. This suggests that both enantiomers are equally likely to be 
formed. Considering the racemic forms, with PBE and both vdW correactions, these are both less 
stable and racemic Form III is by far the least stable.  
However, with the hybrid DFT exchange-correlation functionals, there is a very strong effect on 
the relative energetics of the crystal forms, similar to the crystal structure. For example, with 
HSE06, the R enantiomer is now less stable than the racemic Form II, with the S enantiomer 
continuing to be the most stable. This is found with both vdW corrections so it appears to be 
attributable to the hybrid functional. With the PBE0+vdW hybrid functional, the qualitative trend 
in stability is the same as PBE+vdW, although we note that the relative energies from 
PBE0+vdW indicate that the racemic Form II is close in stabilty to the R enantiomer. Thus, it 
appears that there is a significant sensitivity in the crystal structure and, thus, stability to the DFT 
set-up and the standard hybrid DFT functionals appear to perform less well than the PBE GGA 
functional, irrespective of the vdW corrections used. This may be due to the contribution of exact 
exchange (25%) in PBE0 and HSE06 and, in addition, HSE06 has a screening length of 5 Å, 
which can influence the computational results. However, given the high cost of hybrid DFT 
calculations within the VASP code (ca. 50 times that of a GGA functional calculation), it is not 
practical to test hybrid DFT to obtain a an exact exchange contribution for each system . 
However, the PBE-GGA functional together with vdW corrections does appear to provide a 
reasonable description of the structure and stability of the MPBA system. 
Table 5. Relative DFT energies in kJ mol−1 for the crystal forms of 1 studied. The energy of the 
most stable crystal form for a given DFT approach is set to 0 kJ mol−1. The theoretical methods 
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are explained as follows: PBE-D2: atomic and cell relaxations using PBE with Grimme D2 van 
der Waals correction. PBE-D3: atomic and cell relaxations using PBE with Grimme D3 van der 
Waals correction. HSE06-D2: atomic and cell relaxations using HSE06 with Grimme D2 van der 
Waals correction. HSE06-D3: atomic and cell relaxations using HSE06 with Grimme D3 van der 
Waals correction. PBE0-D2: atomic and cell relaxations using PBE with Grimme D2 van der 




E relative / 
kJ mol−1 
PBE-D3 
E relative / 
kJ mol−1 
HSE06-D2 
E relative / 
kJ mol−1 
HSE06-D3 
E relative / 
kJ mol−1 
PBE0-D2 
E relative / 
kJ mol−1 
PBE0-D3 
E relative / 
kJ mol−1 
Racemic Form II 17 28 28 30 86 27 
Racemic Form III 137 114 234 210 229 117 
R enantiomer 0.2 0 188 173 17 35 
S enantiomer 0 0.96 0 0 0 0 
 
To help understand the differences in stability of the crystal forms we have examined the atomic 
structure and focused on the interactions between molecules of 1 in each crystal form. As 
discussed earlier, each structure has two N-H···O=C hydrogen bonds. The computational data 
using the PBE-D2 level of theory gave similar O···H distances of 1.98 Å in Form III, 2.08 Å in 
Form II, 1.96/2.02 Å in the R enantiomer and 2.07/2.09 Å in the S enantiomer. Thus, this cannot 
be the origin of the different stabilities observed. When we examine the different orientations of 
1 in each form we note that the R, S, and racemic form II structures have adjacent aromatic rings, 
with typical H···H distances of 3.15 – 3.6 Å (typical benzene dimer distances are around 2.5 – 
3.5 Å). However, the racemic Form III is the only structure with no adjacent aromatic rings. It is 
possible that this structure is less stable than the other forms of 1 because the stabilisation 
induced by the aromatic ring interactions is missing. 
Conclusion: 
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In the antimitotic amide 1, the most stable form in the solid state is a conglomerate, Form I. Two 
metastable racemic polymorphs have been identified, Forms II and III, notably with Form II 
isolated by melting Form I followed by vapor crystallization.  The DFT energy calculations 
which include vdW corrections support our hypothesis that the individual enantiomers are more 
energetically favorable than the racemic polymorphs Form II and III. However, it appears that 
hybrid DFT in the guise of the HSE06 and PBE0 functionals with standard exchange 
contributions can have difficulty in describing these systems and, thus, care must be taken in 
applying hybrid DFT. Slurrying experiments revealed that the most stable form was the 
conglomerate in all conditions examined, in agreement with both the initial experimental results 
that identified the different forms and the computational results. This example highlights the 
need to explore as fully as possible the crystal landscape of conglomerates for potential 
polymorphs and the stability behavior of any polymorphs identified. 
Electronic Supplementary Information (ESI) available. Detailed IR, PXRD, DSC data, and 
additional figures. The crystallographic data have been deposited with the Cambridge 
Crystallographic Data Centre, CCDC deposition numbers 1562052-1562055. This material is 
available free of charge via the Internet at http://pubs.acs.org. 
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Exploring the crystal landscape of 3-methyl-2-
phenylbutyramide:  crystallization of metastable 
racemic forms from the stable conglomerate  
U. B. Rao Khandavilli, Declan P. Gavin,
 




Three polymorphs have been identified for the antimitotic amide (±)-3-methyl-2-
phenylbutyramide: a stable conglomerate and two metastable racemates, as evidenced by both 
experimental and theoretical studies. The more stable racemate is obtained by melting the 
conglomerate and crystallizing from the vapor, a rare phenomenon.  
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